Clinical trial
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With…
NCT00235859 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00235859 |
|---|---|
| Title | Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Human Anti-TNF Antibody Adalimumab Administered as Subcutaneous Injections in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate |
| Lead sponsor | Abbott, Industry |
| Collaborators | Eisai Limited Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | adalimumab, methotrexate |
| Enrollment | 128 |
| Start date | Jul 1, 2003 |
| First posted | Oct 12, 2005 |
| Last update posted | Aug 29, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: